6 TIDE STREET, BOSTON, MA
Condensed Consolidated Statement of Comprehensive Income/(Loss) (Unaudited)
Announces Leadership Transition
Announces Board Change
Results of Annual General Meeting
Announces Annual Results for Year Ended December 31, 2024
Statement Regarding Press Speculation
PureTech’s LYT-100 Shows Positive Results in IPF Phase 2b Trial
Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Annual and Transition Report of Foreign Private Issuers
SC TO-I
Tender Offer Statement by Issuer
Certificate
Effectiveness Notice
Direct Registration System
No filings found
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
SEC Staff Action Letter
SEC Staff Correspondence